Northwire Canada EditionSaturday, July 25, 2026
Northwire
B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9% B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9%
Other

Global AI Infrastructure Shift Ignites Biotech Growth Phase

ALEN · Price

Executive Summary

  • Aleen Inc. highlighted the rapid expansion of AI in healthcare and wellness, positioning its non‑diagnostic “Wellness AI” platform for growth.
  • The company announced plans to launch a personal user‑account hub and advanced analytics features in 2026, seeking $20 million–$30 million of strategic investment to fund technology development (35%), sales & marketing (30%) and product expansion (20%).
  • Alee​n emphasized its revenue model (API per‑call fees and subscription plans) and provided market size forecasts for digital wellness ($12.87 bn in 2025, $45.65 bn by 2034).

Key Details

  • Market Context: Global AI‑in‑healthcare market projected to reach $505.59 bn by 2033; digital wellness sector valued at $12.87 bn (2025) and expected to grow to $45.65 bn (2034) (~15.1% CAGR).
  • Product Positioning: Aleen’s Wellness AI platform delivers non‑clinical insights for self‑reflection, explicitly avoiding medical diagnosis or clinical assessment.
  • Platform Access:
  • Free web‑based wellness insights for individual users.
  • API offering for businesses (pay‑per‑call and monthly subscription options).
  • Upcoming Features: Development of a personal account system slated for launch in 2026, providing an integrated hub for users to upload, manage, and visualize non‑medical well‑being data; smart analytics under test.
  • Funding Goal: Seeking $20 M–$30 M strategic investment:
  • 35% allocated to technology development (AI enhancements, account platform).
  • 30% for sales & marketing expansion.
  • 20% for product expansion initiatives.
  • Share Structure: 12,643,300 common shares currently issued and outstanding.
  • Leadership: CEO Inna Aksman; Director Oleksandr Luzin (quoted on platform purpose); PR Specialist Anastasiia Kalashnik (quoted on upcoming features).

Notable Quotes

“Our goal is to help people observe themselves with clarity… Wellness AI is not about diagnosis — it is about reflection, insight, and discovering what your own patterns can teach you.” – Oleksandr Luzin, Director, Aleen Inc.

“We are laying the groundwork for a feature that inspires awareness and self‑reflection, not prescribes actions.” – Anastasiia Kalashnik, PR Specialist, Aleen Inc.

Read the original news release →

More from None